Aspo Pharmaceuticals LLP - pharma in Baddi, Himachal Pradesh, India. FY 2026 financials & compliance.
LLPIN AAL-1485 Incorporated 15 November 2017 ROC Himachal Pradesh HQ Baddi, Himachal Pradesh, India
Active Limited Liability Partnership pharma DPIIT Startup
Data last updated
Revenue · FY 2026
₹28.11 Cr
▲ 1% YoY
Net loss · FY 2026
₹68.11 Lakh
Net margin -2.4%
EBITDA · FY 2026
₹95.08 Lakh
EBITDA margin 3.4%
Contribution obligation
₹2 Cr
As per LLP agreement
Open charges
₹13.99 Cr
Secured borrowings
LLP age
9 yrs
Est. 2017
Employees · EPFO
56
Provident fund records
Designated partners
6
As per MCA filings

About Aspo Pharmaceuticals LLP

Data last updated:

Aspo Pharmaceuticals LLP is a limited liability partnership (LLP) based in Baddi, Himachal Pradesh, India, recognised as a startup by DPIIT. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 15 November 2017 and has been in existence for over 9 years.

The LLP is registered with the Registrar of Companies (ROC), Himachal Pradesh, under LLPIN AAL-1485. Its GSTIN is 02ABKFA2506N1ZM (Himachal Pradesh).

The LLP has a total obligation of contribution of ₹2 Cr. It is led by designated partners including Sanchit Garg and Munish Gupta.

Its latest statement of accounts is for the year ended 31 March 2026. The registered office is at Plot No. 10 Himuda Industrial Area Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.

As per the financials filed for FY 2026, the LLP reported a revenue of ₹28.11 Cr, a growth of 1% compared to the previous year. For the same year it recorded a net loss of ₹68.11 Lakh (net margin -2.4%) and EBITDA of ₹95.08 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 16% over three years and 647% over five years.

The LLP has about 56 employees on its provident fund (EPFO) records.

As per MCA filings, the LLP has open charges of ₹13.99 Cr on record. Court records list 8 cases involving the LLP, including 5 filed by the LLP and 3 filed against it; 4 cases are pending.

Company details

LLPIN AAL-1485
Incorporation Date 15 November 2017
Total Obligation of Contribution ₹2 Cr
ROC Himachal Pradesh
Company Status Active
Date of Last AGM 31 March 2026
Date of Balance Sheet 31 March 2026
DPIIT Recognition Recognised Startup

Recognitions & Rankings of Aspo Pharmaceuticals

DPIIT recognised startup Government of India
Startup India

Contact details

Aspo Pharmaceuticals LLP's registered office is in Baddi, Himachal Pradesh. Its e-mail address is in the company report.

  • Email
  • Registered Address
    Plot No. 10 Himuda Industrial Area Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205
  • Industry
    Pharma, Drug Formulation & Development

To see the full contact details of Aspo Pharmaceuticals LLP, buy the company report.

Comprehensive company report
Aspo Pharmaceuticals LLP - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Aspo Pharmaceuticals LLP

FY 2026 filings available

Aspo Pharmaceuticals LLP reported revenue of ₹28.11 Cr (up 1% YoY) for FY 2026.

Revenue · FY 2026
₹28.11 Cr ▲ 1%
Net loss · FY 2026
₹68.11 Lakh margin -2.4%
EBITDA · FY 2026
₹95.08 Lakh margin 3.4%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 1%
3 years · compounded
▲ 16%
5 years · compounded
▲ 647%
EBITDA CAGR growth
1 year
▼ 49%
3 years · compounded
▼ 20%

Revenue has grown at a compounded annual rate (CAGR) of 647% over five years, including 1% growth in the latest year. EBITDA fell 49% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

Statement of Account and SolvencyFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Income and Expenditure
Turnover₹28.11 Cr
Other Income
Total Income
Purchases and Direct Costs
Personnel Expenses
Administrative Expenses
Interest
Depreciation
Total Expenses
Profit Before Tax
Tax
Profit After Tax-₹68.11 Lakh
Profit Transferred to Partners
Assets and Liabilities
Partners' Contribution
Reserves and Surplus
Secured Loans
Unsecured Loans
Trade Payables
Other Liabilities and Provisions
Total Liabilities
Fixed Assets
Investments
Loans and Advances
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

Statement of Account and SolvencyFY 2025-26FY 2024-25FY 2023-24FY 2022-23FY 2021-22
Profitability
Net Profit Margin-2.4%
Return on Partners' Funds
Return on Assets
Liquidity and Debt
Current Ratio
Debt to Partners' Funds
Interest Coverage
Efficiency and Growth
Asset Turnover
Receivable Days
Turnover Growth
Profit Growth

To see the full financial statements and ratios of Aspo Pharmaceuticals LLP, buy the company report.

Designated partners of Aspo Pharmaceuticals LLP

Aspo Pharmaceuticals has 6 current designated partners and 3 former designated partners. Current designated partners are listed first, with their designation and appointment date.

Current Designated Partners
NameDesignationAppointment DateTenureStatus
Sanchit GargDesignated Partner19 Jul 20188 Years 3 MonthsCurrent
Munish GuptaDesignated Partner19 Jul 20188 Years 3 MonthsCurrent
Deepak GuptaDesignated Partner19 Jul 20188 Years 3 MonthsCurrent
Vikas GuptaDesignated Partner19 Jul 20188 Years 3 MonthsCurrent
Arvind JindalDesignated Partner01 Jun 20215 Years 5 MonthsCurrent
Vivek JindalDesignated Partner01 Jun 20215 Years 5 MonthsCurrent

Charges & borrowings

Open charges
₹13.99 Cr
Satisfied charges
None
Breakdown by lending institutions
Punjab National Bank₹13.99 Cr
Latest charge details
DateCharge IDLenderAmountStatusModified or satisfied on
11 Jun 2026101334960Punjab National Bank₹1.25 CrOpen
17 Oct 2025101182003Punjab National Bank₹18.34 LakhOpen
17 Oct 2025101182008Punjab National Bank₹18.34 LakhOpen
18 Jun 2022100631628Punjab National Bank₹81 LakhOpen
11 Nov 2021100495241Punjab National Bank₹5.68 LakhOpen

To see the full charge records of Aspo Pharmaceuticals LLP, buy the company report.

Total charge records: 7 View all charges

MSME payment delays

No delayed payments to MSME suppliers are on our record for Aspo Pharmaceuticals LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

Employees & EPFO

Aspo Pharmaceuticals LLP has a workforce of 56 employees on its EPFO records as of May 2026, across 1 active EPFO establishment.

Employee count
56
Active EPFO establishments
1
Employee growth
-26.3%

Headcount by financial year

Financial yearEmployees (EPFO)
FY 2026-2756
FY 2025-26
FY 2024-25
FY 2023-24
FY 2022-23
FY 2021-22

To see the full employee and EPFO history of Aspo Pharmaceuticals LLP, buy the company report.

GST

Aspo Pharmaceuticals has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
02ABKFA2506N1ZMHimachal PradeshActive27 Feb 2018

To see the full GST registrations and return filing status of Aspo Pharmaceuticals LLP, buy the company report.

Recent activity

Aspo Pharmaceuticals LLP has 9 designated partner changes on record since 2018: 6 appointments and 3 cessations. The latest: Arvind Jindal was appointed as Designated Partner on 01 Jun 2021.

Charges
A charge with Punjab National Bank amounted to Rs. 1.25 Cr with Charge ID 101334960 was registered on 11 Jun 2026.
AGM
Aspo Pharmaceuticals Llp last Annual general meeting of members was held on 31 Mar 2026 as per latest MCA records.
Filing
Aspo Pharmaceuticals Llp has filed its annual Financial statements for the year ended 31 Mar 2026 with Roc Himachal Pradesh.
Charges
A charge with Punjab National Bank amounted to Rs. 0.18 Cr with Charge ID 101182003 was registered on 17 Oct 2025.
Charges
A charge with Punjab National Bank amounted to Rs. 0.18 Cr with Charge ID 101182008 was registered on 17 Oct 2025.
Charges
A charge with Punjab National Bank of Rs. 11.10 Cr registered on 15 Jul 2019 with Charge ID 100281298 was modified on 31 May 2025.
Charges
A charge with Punjab National Bank amounted to Rs. 0.81 Cr with Charge ID 100631628 was registered on 18 Jun 2022.
Charges
A charge with Punjab National Bank amounted to Rs. 0.06 Cr with Charge ID 100495241 was registered on 11 Nov 2021.
Charges
A charge with Punjab National Bank amounted to Rs. 0.41 Cr with Charge ID 100495615 was registered on 11 Nov 2021.
Appointed
Arvind Jindal was appointed as Designated Partner.
Appointed
Vivek Jindal was appointed as Designated Partner.
Charges
A charge with Punjab National Bank amounted to Rs. 11.10 Cr with Charge ID 100281298 was registered on 15 Jul 2019.

8 earlier events are in the company report.

Frequently asked questions

Aspo Pharmaceuticals is an active limited liability partnership based in Baddi, Himachal Pradesh, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 15 November 2017 (9+ years old) and is registered under LLPIN AAL-1485.

Aspo Pharmaceuticals has 6 current designated partners:

The latest financial statements of Aspo Pharmaceuticals on record with the MCA are for the year ended 31 March 2026. Its last annual general meeting was held on 31 March 2026. Year-wise statements from FY 2018 are in the company report.

The GSTIN of Aspo Pharmaceuticals is 02ABKFA2506N1ZM, registered in Himachal Pradesh.

The LLPIN (Limited Liability Partnership Identification Number) of Aspo Pharmaceuticals is AAL-1485. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.

Aspo Pharmaceuticals has 8 court cases on record: 5 filed by the LLP and 3 filed against it. 4 are pending. Most are in the district courts.

Aspo Pharmaceuticals was incorporated on 15 November 2017, making it 9+ years old. It is registered with the Registrar of Companies, Himachal Pradesh.

Arvind Jindal was appointed as Designated Partner on 01 Jun 2021. Vivek Jindal was appointed as Designated Partner on 01 Jun 2021. Amit Garg ceased to be Designated Partner on 23 Aug 2018. Aspo Pharmaceuticals has 9 designated partner changes on record in total.

Yes, Aspo Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).

The registered office of Aspo Pharmaceuticals is at Plot No. 10 Himuda Industrial Area Bhatoli Kalan, Baddi, Himachal Pradesh, India – 173205.